Food pipe (oesophagus) cancer
Comparative study of different dose regimens for neoadjvant chemoradiotherapy in operable squamous cell carcinoma of oesophagus
Who can joinAsk the trial team
AgeAsk the trial team
Kind of studyPhase 2: does it work?
What it testsA medicine and surgery or a procedure
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Dr Bhubaneswar Borooah Cancer InstituteBhubaneswarDirections ↗
Registry summary (technical)
COMPARATIVE STUDY OF TWO DIFFERENT DOSE FRACTIONATION SCHEDULES OF NEOADJUVANT CHEMORADIOTHERAPY IN RESECTABLE SQUAMOUS CELL CARCINOMA OF ESOPHAGUS: A PHASE II RANDOMISED CONTROLLED TRIAL - NIL
Sponsor: Dr B Borooah Cancer Institute
CTRI/2026/03/107132 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 27 Apr 2026 · read by us 5 Nov 2026